Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blinded, Adaptive Phase 2 Study to Evaluate the Safety and Efficacy of Oral Omadacycline and Oral Nitrofurantoin in the Treatment of Female Adults With Cystitis
Conditions
Interventions
Omadacycline tablets
Nitrofurantoin capsules
Locations
23
United States
Site 106
Chula Vista, California, United States
Site 101
La Mesa, California, United States
Site 109
Los Angeles, California, United States
Site 114
Aventura, Florida, United States
Site 102
DeLand, Florida, United States
Site 103
Hialeah, Florida, United States
Start Date
January 4, 2018
Primary Completion Date
May 15, 2019
Completion Date
June 5, 2019
Last Updated
June 9, 2020
NCT05893511
NCT07495072
NCT07391306
NCT05737121
NCT00389142
NCT05726786
Lead Sponsor
Paratek Pharmaceuticals Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions